What Does It Cost to Create a Cancer Drug? Less Than You’d Think
A new study suggests that biotech companies are spending far less than believed on research and development for approved drugs, despite rising prices.
Advertisement
A new study suggests that biotech companies are spending far less than believed on research and development for approved drugs, despite rising prices.
By GINA KOLATA
Now in their 20s, they urge the youngest survivors of Harvey and Irma to seek stability from one ‘solid anchor’ — a parent, teacher, pastor or sibling
By BENEDICT CAREY
Some patients taking antidepressants experience nearly intolerable agitation, a side effect that experts say may be linked to suicide.
By RONI CARYN RABIN
Under a novel deal, Allergan will pay the Saint Regis Mohawk tribe $13.75 million. In exchange, the tribe will claim sovereign immunity as grounds to dismiss a patent challenge.
By KATIE THOMAS
The agency said Pfizer ignored hundreds of complaints that the device failed to operate in life-threatening emergencies, including incidents when patients died.
By KATIE THOMAS
From Southern California to the South Pacific, reports of nonnative species are rising.
By DONALD G. McNEIL Jr.
The hospital, Baptist Beaumont, was one of many health care institutions disrupted as the storm Harvey, once a Category 4 hurricane, swept across the region.
By SHERI FINK and ANDREW BURTON
A property owner rolled the silvery globules around in the palm of his hand before he realized they were clusters of mercury, a dangerous liquid metal.
By JACK HEALY and SHEILA KAPLAN
The prestigious awards come during a time of uncertainty for reproductive health care in the United States.
By HEATHER MURPHY